IBM vs Innoscience
IBM is larger by market cap ($224.6B vs $5.2B). IBM reports higher tracked revenue ($67.5B vs $180M). IBM's primary segment is Hyperscalers; Innoscience's is Integrated Device Manufacturer.
Shared segment: IDM.
Side-by-side
| IBM | Innoscience | |
|---|---|---|
| Market cap | $224.6B | $5.2B |
| Revenue | $67.5B (FY2025) | $180M (FY2025) |
| Primary segment | Hyperscalers | Integrated Device Manufacturer |
| Market position | major | leader |
| Country | United States | China |
| Tracked suppliers | 6 | 1 |
| Tracked customers | 1 | 2 |
| Chokepoint / criticality | 68/100 | 81/100 |
Market caps/revenue from the wafergraph dataset · data as of 2026-08-12. Criticality is a graph-derived chokepoint score (0–100). Coverage is partial; "Unpriced" means no reliable market cap.
How IBM and Innoscience compare
- Size: IBM is the larger company by market cap.
- Revenue: IBM reports higher tracked revenue.
- Supply-chain criticality: Innoscience has the higher chokepoint score (81/100 vs 68/100).
- Footprint: IBM (United States) vs Innoscience (China).